This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT): Acorda Therapeutics Inc (ACOR), Nektar Therapeutics (NKTR)
According to most traders, hedge funds are perceived as underperforming, old investment tools of yesteryear.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
News
- First
- << Previous
- 161 - 170
- Next >>
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Is This the Next Investing Bubble?
With the Nasdaq Biotechnology Index hitting record highs, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to chat about whether we're in a biotech bubble.
Antares Pharma Inc (ATRS), ARMOUR Residential REIT, Inc. (ARR): 5 Fast Growers for Your Consideration
When building your portfolio, aim for diversification. You should aim to hold both large and small companies (plus mid-sized ones) and companies in a range of industries.
3 Earnings Reports That Caught My Attention Last Week: Ciena Corporation (CIEN), Smith & Wesson Holding Corporation (SWHC)
As first-quarter earnings begin to wind down, I can't help but point out that the majority of earnings reports we've covered over the past year have been better than expected.
What You Need to Know About Sarepta Therapeutics Inc (SRPT)'s Q4 Update
Sarepta Therapeutics Inc (NASDAQ:SRPT) was on fire in 2012, landing at the top of the list of The Motley Fool's best health-care stocks of the year.
Can't-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
Here's What George Soros Has Been Buying and Selling: RF Micro Devices, Inc. (RFMD) and More
George Soros is known to some folks these days for his politics and philanthropy, but his fame stems from his wealth, which is a result of his outstanding investing prowess.
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target
How many of us as investors want to identify companies that are pioneers in their industry? Is it possible to find commonality across sectors, which factors make specific companies great and cause other...
StemCells, Inc. (STEM) Have a Long Way to Go: Sarepta Therapeutics Inc (SRPT)
StemCells, Inc. (NASDAQ:STEM) stock jumped more than 20% after the biotech released long-term data for its neural stem cell product HuCNS-SC, but investors seem to be coming to their senses today, knocking...
What's Next for Sarepta Therapeutics Inc (SRPT)?
What's next for Sarepta Therapeutics Inc (NASDAQ:SRPT) ? After announcing encouraging results last October from a phase 2b study of eteplirsen targeting treatment of Duchenne muscular dystrophy, or DMD...
- First
- << Previous
- 161 - 170
- Next >>
Billionaire Hedge Funds
